Biosketch
Dr. Tan Yong Chuan graduated from the Yong Loo Lin School of Medicine, National University of Singapore (NUS). He went on to obtain postgraduate qualifications including the Membership of the Royal Colleges of Physicians of the United Kingdom and the Master of Medicine (Internal Medicine) from NUS. He also holds a Graduate Diploma in Family Medicine from NUS.
He completed his residency training in Internal Medicine at Singapore General Hospital, before pursuing senior residency training in Gastroenterology and Hepatology at the National University Hospital.
Dr. Tan’s clinical and research interests are in Hepatology, with a particular focus on chronic hepatitis B. He has published in leading international journals including Journal of Hepatology, Gastroenterology, and Liver International. In recognition of his work on novel treatment strategies for chronic hepatitis B, he was awarded the competitive NUHS Clinician-Scientist Programme (CSP) 2.0 Grant, which supports his efforts to advance translational therapeutics for liver disease.
In addition to his clinical practice, Dr. Tan is committed to teaching and mentorship, guiding medical students, residents, and junior doctors in gastroenterology and hepatology. He is also involved in public education and advocacy, having shared his expertise at a community forum to promote awareness of liver health.
Journals & Publications
1. Lim SG, Tan YC. Additional Measures After Stopping Nucleoside Analogues in HbeAg-Negative Chronic Hepatitis B: Better But Not Enough. Gastroenterology. 2024 Jan;166(1):23-24. doi: 10.1053/j.gastro.2023.10.005. Epub 2023 Oct 12.PMID: 37832923. [IF - 25.7]
2. Lim SG, Yeo EJ, Adraneda C, Tan YC. Reply to: "Improved basic performance of iTACT-HBcrAg assay" and "Using a commercial diagnostic assay requires compliance with the manufacturer's recommendations". J Hepatol. 2023 Sep;79(3):e136-e137. doi: 10.1016/j.jhep.2023.05.047. Epub 2023 Jun 29. PMID: 37392839. [IF - 26.8]
3. Adraneda C*, Tan YC*, Yeo EJ, Kew GS, Khakpoor A, Lim SG. A critique and systematic review of the clinical utility of hepatitis B core-related antigen. J Hepatol. 2023 Apr;78(4):731-741. doi: 10.1016/j.jhep.2022.12.017. Epub 2022 Dec 28. PMID: 36586590. *co-first authors [IF - 26.8]
4. Tan YC, Lee GH, Huang DQ, Lim SG. Future anti-HDV treatment strategies, including those aimed at HBV functional cure. Liver Int. 2023 Jun;43(6):1157-1169. doi: 10.1111/liv.15387. Epub 2022 Sep 1. PMID: 35946084. [IF - 6.0]
5. Chuan TY, Mun WL, Siang WH. An 86-Year-Old Woman Presenting With 2 Weeks of Worsening Dyspnea and Cough. Chest. 2021 Feb;159(2):e103-e106. doi: 10.1016/j.chest.2020.09.080. PMID: 33563451. [IF - 9.5]
6. Tiew WJ, Wong VL, Tan VH, Tan YC, Lee EM. A Real-world Experience of the Safety and Efficacy of Non-vitamin K Oral Anticoagulants Versus Warfarin in Patients with Non-valvular Atrial Fibrillation-A Single-centre Retrospective Cohort Study in Singapore. Ann Acad Med Singap. 2020 Nov;49(11):838-847. doi: 10.47102/annals-acadmedsg.2020184. PMID: 33381777. [IF - 2.5]
